V.TLT
|
I think that site is written by Chinese air bots.
|
V.TLT
|
Isn't pre-market approval = AA? Not sure what study device refers...
|
V.TLT
|
I think that is about right as a 'good value' for a pharma...
|
V.TLT
|
I agree with ya on the Venture, never again. I do like what I'm seeing...
|
V.TLT
|
Everyone knows that 'drugs' that work in rats have only about a 15...
|
V.TLT
|
I have to say FGP, Big is probably correct. PDCs are less drug, more of a...
|
V.TLT
|
Oh and yeah, setting up a Fidelity account online, went smooth including ...
|
V.TLT
|
I bought mine through Fidelity. Need to talk to their international desk by...
|
V.TLT
|
It Will be interesting where it opens tomorrow. I won't panic. BTD then...
|
V.TLT
|
Exactly, she is there for jv facilitation. Doesn't hurt that she is hot...
|
V.TLT
|
I've got goosebumps! OK that is a bit much...
|
V.TLT
|
Graham, The only things I look at, as a long term holder of TLT, is what is...
|
V.TLT
|
looking good to me...
|
V.TLT
|
The warrants that are tradeable expire end of Aug 2024, for .5c those are a...
|
V.TLT
|
Hey, long time investor here. It is summer. I think once fall comes around...
|
V.TLT
|
A JV will probably happen before then River.
|
V.TLT
|
I think TLTs bacterium/virii portfolio is important tech that some pharma...
|
V.TLT
|
Yep we should get AA because of this fairly soon, IMO. Then a JV, or buyout...
|
V.TLT
|
I think it is probably too strong to call this ACT from TLT a 'cure'....
|
V.TLT
|
Nice to see TLT get their patents lined up, great job Pando!
|